Lilly’s Trulicity applied for national health insurance benefit in combination with insulin

Published: 2017-10-12 14:46:06

Updated: 2017-10-12 14:46:06

Lilly Korea(CEO Paul Henry Huibers) announced the Ministry of Health and Welfare’s national health insurance benefit standards were extensively revised under a revision bill for ‘Trulicity(generic name: dulaglutide)’ to be used with health insurance benefits in combination with insulin on the 1^st of October.

The revision will now accept the health insurance benefits for Trulicity in combinatio...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.